tropisetron

Small moleculeexperimental

Tropisetron is a serotonin 5-HT3 receptor antagonist used mainly as an antiemetic to treat nausea and vomiting following chemotherapy, although it has been used experimentally as an analgesic in cases of fibromyalgia. — Wikipedia

Clinical trial activity

21 trials · 26 clinical orgs · 0 marketing orgs

Phase 1
1
Phase 2
7
Phase 3
4
Phase 4
8

Earliest trial started Oct 1, 1999 (NCT00003817)

Timeline

1990s

  1. Jan 1, 1999

    Earliest Phase 2 Sponsor(trial)

2000s

  1. Jan 1, 2006

    Earliest Phase 3 Sponsor(trial)

2020s

  1. Jan 1, 2022

    Earliest Phase 1 Sponsor(trial)

Indications

Approved for

Mechanism of action

Chemistry & pharmacology

Loading structure…

SMILES

CN1[C@@H]2CC[C@H]1C[C@@H](OC(=O)c1c[nH]c3ccccc13)C2
Mol. weight
284.36 g/mol
Lipinski Ro5
Pass
Rule of 3
Yes
Chirality
Single Stereoisomer
Inorganic
No
Polymer
No

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • 1h-indole-3-carboxylic acid, 8-methyl-8-azabicyclo(3.2.1)oct-3-yl ester, endo-
  • (3 alpha-tropanyl)-1h-indole-3-carboxylic acid ester
  • ics 205-930
  • ics-205930
  • ics-205-930
  • ics-205-930
  • ics-205-930
  • indole-3-carboxylic acid tropine ester
  • navoban
  • navoban
  • navoban
  • navoban
  • novartis brand of tropisetron hydrochloride
  • tropisetron
  • tropisetron
  • tropisetron
  • tropisetron
  • tropisetron
  • tropisetron
  • tropisetron
  • tropisetron
  • tropisetron hcl
  • tropisetron hydrochloride
  • tropisetron hydrochloride

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT05533281Early Phase 1 (Phase 1)Sep 15, 2022Chongqing Medical University
NCT05331651Phase 4Apr 8, 2022Chongqing Medical University, Ninth People's Hospital of Chongqing, People's Liberation Army of China, The People's Hospital of Nanchuan
NCT05242874Phase 3Jan 1, 2022Henan Medical University
NCT05564286Phase 3Jul 1, 2021Shantou University
NCT04817189Phase 4Feb 1, 2021Helsinn, The Hong Kong Polytechnic University
NCT04195204Phase 4Dec 31, 2019Capital Medical University
NCT04027751Phase 4Aug 1, 2019Capital Medical University
NCT03540537N/AJul 1, 2018Southern Medical University
NCT02909478Phase 3Dec 1, 2016Sun Yat-Sen University
NCT02625181N/AJul 1, 2016University of Washington, Vanderbilt University
NCT02576327Phase 4Oct 1, 2015Peking University
NCT02478047N/AJun 1, 2015National Basic Research Program, China, Tianjin University of Traditional Chinese Medicine
NCT02096835N/AJan 1, 2014Fudan University
NCT01895010Phase 2Jun 1, 2013Fudan University
NCT01636947Phase 4Dec 12, 2012Merck
NCT01304953Phase 4Jan 1, 2010Huazhong University of Science and Technology
NCT00970450N/ANov 1, 2009University of Bern
NCT00889499Phase 2Mar 1, 2009University of Bern
NCT00487110Phase 4Jun 1, 2008University Clermont Auvergne
NCT00435370Phase 3Nov 1, 2006Baylor University, National Institute of Mental Health (NIMH)
Showing 20 of 21 trials
Page 1 / 2

Organizations

Research & Development (26)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Capital Medical UniversityAcademic/Hospital2212019
Chongqing Medical UniversityAcademic/Hospital2222022
Fudan UniversityAcademic/Hospital2222013
University of BernAcademic/Hospital2222009
Baylor UniversityAcademic/Hospital1112006
HelsinnFor profit1112021
Henan Medical UniversityAcademic/Hospital1112022
Huazhong University of Science and TechnologyAcademic/Hospital1112010
MerckFor profit1112012
National Basic Research Program, ChinaAcademic/Hospital1012015
National Cancer Institute (NCI)Government1011999
National Institute of Mental Health (NIMH)Government1012006
New York UniversityAcademic/Hospital1011999
Ninth People's Hospital of ChongqingAcademic/Hospital1012022
Peking UniversityAcademic/Hospital1112015
People's Liberation Army of ChinaGovernment1012022
Shantou UniversityAcademic/Hospital1112021
Southern Medical UniversityAcademic/Hospital1112018
Sun Yat-Sen UniversityAcademic/Hospital1112016
The Hong Kong Polytechnic UniversityAcademic/Hospital1012021
26 organizations
Page 1 / 2